In view of this, tumor tissue may be limited to a long list of investigations, and incorporating multiple IHC marker panels may not be practical; therefore, identification of SMARCA4 among the panel of other genetic markers of interest through NGS-based strategies may be more ideal [6]. Here, SMARCA4 is linked to neoplasm.